Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelium dysfunction in the coronary circulation

T F Lüscher1, G Noll

  • 1University Hospital, Bern, Switzerland.

Journal of Cardiovascular Pharmacology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome.

International journal of cardiology·2016
Same author

[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Der Internist·2014
Same author

The antiproliferative effect of pinostrobin on human umbilical vein endothelial cells (HUVEC).

European review for medical and pharmacological sciences·2013
Same author

Management of hypertension in patients with diabetes mellitus and metabolic syndrome in Swiss primary care.

International journal of clinical practice·2012
Same author

[Effect of paracetamol (acetaminophen) on blood pressure in patients with coronary heart disease].

Praxis·2012
Same author

[Heart failure. 2: Therapy].

Praxis·2010
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
Same journal

The Therapeutic Role of Exercise in Diabetic Cardiomyopathy: Underlying Mechanisms and Interactions with Antidiabetic Medications.

Journal of cardiovascular pharmacology·2026
Same journal

Cardiovascular Adverse Events Associated with Immune Checkpoint Inhibitors from the Perspective of Gut Microecology: Potential Roles and Research Advances of the Gut Microbiota.

Journal of cardiovascular pharmacology·2026
See all related articles

Coronary artery disease (CAD) involves endothelial dysfunction, leading to increased vasoconstriction and cell interactions. Improving endothelial function may offer promising therapeutic strategies for preventing and treating CAD.

Area of Science:

  • Cardiovascular Science
  • Vascular Biology
  • Pathophysiology

Background:

  • Coronary artery disease (CAD) is a leading cause of death in Western countries.
  • Its pathogenesis involves vasoconstriction, platelet/monocyte interaction, and smooth muscle cell proliferation.
  • Endothelial cells play a critical role in regulating vascular tone and cell adhesion.

Purpose of the Study:

  • To explore the role of endothelial cells in the pathogenesis of coronary artery disease.
  • To understand how endothelial dysfunction contributes to CAD development.
  • To evaluate the therapeutic potential of targeting endothelial function in CAD.

Main Methods:

  • Review of existing literature on endothelial cell function and CAD.
  • Analysis of the mechanisms underlying endothelial dysfunction in cardiovascular risk factors.

Related Experiment Videos

  • Examination of the vasoactive and cellular effects of endothelial cells.

    • Main Results:

    • Endothelial cells normally inhibit platelet/monocyte adhesion and promote vasodilation.
    • Endothelial dysfunction exacerbates vasoconstriction and cell proliferation in CAD.
    • Dysfunctional endothelium shows reduced vasodilation and increased constrictor responses.

    Conclusions:

    • Endothelial cells are key mediators and targets in coronary artery disease.
    • Therapeutic strategies focused on enhancing endothelial function show promise for CAD prevention and treatment.